620P MGC018, an anti-B7-H3 antibody-drug conjugate (ADC), in patients with advanced solid tumors: Preliminary results of phase I cohort expansion. - Shenderov, E.; Mallesara, G.H.G.; Wysocki, P.J.; Xu, W.; Ramlau, R.; Weickhardt, A.J.; Zolnierek, J.; Spira, A.; Joshua, A.M.; Powderly, J.; Antonarakis, E.S.; Jang, S.; et al. (Annals of Oncology, 2021)